These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8390426)

  • 1. Inhibition of cisplatin-mediated DNA damage in vitro by ribonucleotides.
    Seki S; Hongo A; Zhang B; Akiyama K; Sarker AH; Kudo T
    Jpn J Cancer Res; 1993 Apr; 84(4):462-7. PubMed ID: 8390426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and analyses by gel electrophoresis of cisplatin-mediated DNA damage.
    Zhang B; Seki S; Akiyama K; Tsutsui K; Li T; Nagao K
    Acta Med Okayama; 1992 Dec; 46(6):427-34. PubMed ID: 1336637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of nucleoside triphosphate inhibition of liver glycogen synthase phosphatase activity.
    Gilboe DP; Nuttall FQ
    Biochim Biophys Acta; 1989 May; 991(2):340-6. PubMed ID: 2541795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of in vitro platinum-DNA adduct formation between carboplatin and cisplatin.
    Hongo A; Seki S; Akiyama K; Kudo T
    Int J Biochem; 1994 Aug; 26(8):1009-16. PubMed ID: 8088411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship of a pyrimidine receptor in the rat isolated superior cervical ganglion.
    Connolly GP; Harrison PJ
    Br J Pharmacol; 1995 Nov; 116(6):2764-70. PubMed ID: 8591002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent.
    Burstyn JN; Heiger-Bernays WJ; Cohen SM; Lippard SJ
    Nucleic Acids Res; 2000 Nov; 28(21):4237-43. PubMed ID: 11058123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
    Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
    Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of nucleoside triphosphates on nucleolar RNA synthesis.
    Nagamine Y; Mizuno D; Natori S
    J Biochem; 1979 Mar; 85(3):839-45. PubMed ID: 34601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of several nucleoside triphosphate analogues and 10-hydroxycamptothecin with human DNA topoisomerases.
    Liu SY; Hwang BD; Liu ZC; Cheng YC
    Cancer Res; 1989 Mar; 49(6):1366-70. PubMed ID: 2538224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity.
    McDonald ES; Randon KR; Knight A; Windebank AJ
    Neurobiol Dis; 2005 Mar; 18(2):305-13. PubMed ID: 15686959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage by restriction enzymes of DNA modified with the antitumour drug cis-diamminedichloroplatinum(II).
    Balcarová Z; Mrázek J; Kleinwächter V; Brabec V
    Gen Physiol Biophys; 1992 Dec; 11(6):579-88. PubMed ID: 1338050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.
    Mohanty JG; Raible DG; McDermott LJ; Pelleg A; Schulman ES
    J Allergy Clin Immunol; 2001 May; 107(5):849-55. PubMed ID: 11344352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced levels of cyclic AMP, adenosine(5')tetraphospho(5')adenosine and nucleoside 5'-triphosphates in mouse leukemia P388/D1 after treatment with cis-diamminedichloroplatinum(II).
    Just G; Holler E
    Biochem Pharmacol; 1991 Jul; 42(2):285-94. PubMed ID: 1650208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Separation of natural ribonucleoside triphosphates and their determination in an acid-soluble cell fraction by anion exchange high performance liquid chromatography].
    Korbukh IA; Stukalov IuV; Zimakova NI; Preobrazhenskaia MN
    Bioorg Khim; 1983 Dec; 9(12):1644-9. PubMed ID: 6679763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
    Knox RJ; Friedlos F; Lydall DA; Roberts JJ
    Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside triphosphates promote the transformation of Ah receptor to its DNA-binding form.
    Cary AJ; Dougherty JJ
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):401-4. PubMed ID: 1848756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin-DNA damage in p21WAF1/Cip1 deficient mouse keratinocytes exposed to cisplatin.
    van Gijssel HE; Leil TA; Weinberg WC; Divi RL; Olivero OA; Poirier MC
    Mutagenesis; 2007 Jan; 22(1):49-54. PubMed ID: 17158520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cis-Diamminedichloroplatinum (II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats.
    Reed E; Litterst CL; Thill CC; Yuspa SH; Poirier MC
    Cancer Res; 1987 Feb; 47(3):718-22. PubMed ID: 3802077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG1 protein inhibits the translesion synthesis of the major DNA cisplatin adduct by cell extracts.
    Hoffmann JS; Locker D; Villani G; Leng M
    J Mol Biol; 1997 Jul; 270(4):539-43. PubMed ID: 9245584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of DNA dynamics by platinum drug binding: a time-dependent fluorescence depolarization study of the interaction of cis- and trans-diamminedichloroplatinum(II) with DNA.
    Millar DP; Ho KM; Aroney MJ
    Biochemistry; 1988 Nov; 27(23):8599-606. PubMed ID: 3219364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.